SK
Steve H Kanzer
10% Owner

Steve H Kanzer insider trades: Synthetic Biologics (SYN) stock buys and sales

10% Owner, Synthetic Biologics Last trade Apr 30, 2014 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2006
6
Companies
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Steve reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 30, 2014SYN↓ Sell$7.2M
Apr 29, 2014SYN↓ Sell$763K
Apr 11, 2008PP↑ Buy$44K
Jul 25, 2007PP↑ Buy$103K
Jul 24, 2007PP↑ Buy$57K
Jul 23, 2007PP↑ Buy$200K
Jul 17, 2007PP↑ Buy$131K
Jul 16, 2007PP↑ Buy$392K
May 11, 2007PPEX↑ Buy$140K
Apr 17, 2007PPXP↑ Buy$446K
Feb 9, 2007DOR↑ Buy$100K
Nov 2, 2006PP↑ Buy$4.7M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Steve H Kanzer's insider trades

Steve H Kanzer is a 10% owner of Synthetic Biologics (SYN). Since Nov 2, 2006, Steve has reported 10 open-market purchases worth $6.4M and 2 sales worth $7.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SYN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.